FindTrial
Sign In

Plasma ctDNA detection in precise diagnosis and personalized treatment of ovarian cancer

Peripheral blood plasma ctDNA detection in precise diagnosis and personalized treatment of ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009486
Enrollment
Unknown
Registered
2016-10-19
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Gold Standard:
Index test:

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 16years and more; 2. Diagnosis of ovarian cancer is confirmed by two Pathologists independently; 3. Pregnancy tests are negative.

Exclusion criteria

Exclusion criteria: 1. With other type of malignancies; 2. someone who refuse to participate the study.

Design outcomes

Primary

MeasureTime frame
ctDNA mutation;—

Countries

China

Contacts

Public ContactYu Wang

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

renjiwangyu@126.com+86 18918358318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026